2016
DOI: 10.4172/2368-0512.1000070
|View full text |Cite
|
Sign up to set email alerts
|

Acetylsalicylic acid use in primary prevention in Canada: Insight from the Primary Care Audit of Global Risk Management (PARADIGM) study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…The age and the use of aspirin was significantly associated, in which aspirin use was more with increasing age , in those whose ages more than 60 years (120 patients) 97 of them taking aspirin p value 0.003. In a study conducted in Canada that prospectively enrolled 3015 patients without any previous CVS diseases for aspirin use as primary protection , when compared with their counterparts, the study found that , peoples receiving aspirin were older their ages in years was 61.6±8.4 vs. 55.5±8.1 with (P<0.0001) (13) A significant association was also found between gender and use of aspirin in which aspirin use was more in females patients with p value is 0.04. A similar results was found by a study of mendy et al in USA on the aspirin use in primary protection in patients without prior CVS diseases, they found that aspirin use was more in female(45.9% ) than in male(39.1% ) (14) .This may because of female in our communities look for and afraid more about their health status.…”
Section: Discussionmentioning
confidence: 99%
“…The age and the use of aspirin was significantly associated, in which aspirin use was more with increasing age , in those whose ages more than 60 years (120 patients) 97 of them taking aspirin p value 0.003. In a study conducted in Canada that prospectively enrolled 3015 patients without any previous CVS diseases for aspirin use as primary protection , when compared with their counterparts, the study found that , peoples receiving aspirin were older their ages in years was 61.6±8.4 vs. 55.5±8.1 with (P<0.0001) (13) A significant association was also found between gender and use of aspirin in which aspirin use was more in females patients with p value is 0.04. A similar results was found by a study of mendy et al in USA on the aspirin use in primary protection in patients without prior CVS diseases, they found that aspirin use was more in female(45.9% ) than in male(39.1% ) (14) .This may because of female in our communities look for and afraid more about their health status.…”
Section: Discussionmentioning
confidence: 99%